Diabetes, Vol 43, Issue 1 154-160, Copyright © 1994 by American Diabetes Association

ARTICLES

Associations of anti-GAD antibodies with islet cell antibodies and insulin autoantibodies in first-degree relatives of type I diabetic patients

U Roll, MR Christie, E Standl and AG Ziegler
Diabetes Research Institute, Schwabing-City-Hospital, Munich, Germany.

Sera from 114 first-degree relatives of insulin-dependent diabetes mellitus (type I diabetes) patients and 81 healthy individuals living in Germany were analyzed for antibodies to rat brain glutamic acid decarboxylase (GAD-ab) using an immunoprecipitation assay. The determination of GAD-ab in the 81 islet cell antibody (ICA) and insulin autoantibody (IAA) negative healthy individuals established a normal range (mean +/- 2 SD); 2 healthy individuals (2.5%) possessed GAD-ab levels above this range, but became negative on follow-up. None of 86 ICA-/IAA- first-degree relatives had GAD-ab; whereas, 42.9% of 28 ICA+ and/or IAA+ relatives were positive for GAD-ab. Presence of GAD-ab was negatively correlated with IAA (P = 0.02) and positively with ICA (P = 0.0006). Follow-up samples were obtained from 25 of 28 ICA+ and/or IAA+ relatives with a mean (+/- SD) follow-up period of 20.6 +/- 12.1 months. In these 25 relatives, GAD-ab were positive in 70% ICA+/IAA-, 0% ICA-/IAA+, and 57.1% ICA+/IAA+ relatives in the first sample and in 57.1% ICA+/IAA-, 0% ICA-/IAA+, and 70% ICA+/IAA+ relatives in the last sample. GAD-ab, once detected, persisted in 9 of 11 GAD-ab+ relatives. Of the relatives, 2 converted to GAD-positivity, concomitant with the appearance of ICA, and 2 others lost GAD-ab during follow-up. Of the 28 ICA+ and/or IAA+ relatives, 6 progressed to overt type I diabetes on follow-up, and GAD-ab were detectable in 4 of these relatives.(ABSTRACT TRUNCATED AT 250 WORDS)
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. Zeidler, L. J. Raffel, G. Costin, S. J. Shaw, T. A. Buchanan, J. Noble, J. I. Rotter, J. Palmer, J. P. Krischer, C. Wait, et al. Autoantibodies and Human Leucocyte Antigen Class II in First-Degree Family Members of Mexican-American Type 1 Diabetic Patients J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4957 - 4962. [Abstract] [Full Text] [PDF]

				C. S. Hampe, E. Örtqvist, O. Rolandsson, M. Landin-Olsson, C. Törn, A. Ågren, B. Persson, D. B. Schranz, and A. Lernmark Species-Specific Autoantibodies in Type 1 Diabetes J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 643 - 648. [Abstract] [Full Text]

				R. H. Slover and G. S. Eisenbarth Prevention of Type I Diabetes and Recurrent {beta}-Cell Destruction of Transplanted Islets Endocr. Rev., April 1, 1997; 18(2): 241 - 258. [Abstract] [Full Text]